AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitalembic M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitalembic M 50mg/500mg Tablet

Combiflex DM 50mg/500mg tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Combiflex DM 50mg/500mg may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized, considering your health status, glucose levels, and other medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes efficacy; discontinuation requires medical consultation. Adherence to your doctor's dietary and exercise plan is crucial for diabetes control; lifestyle significantly impacts management. Common side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; learn to identify and treat it. This medication isn't for everyone. Inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or lactating individuals should seek medical advice. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and glucose levels throughout treatment.

Uses of Sitalembic M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitalembic M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Sitalembic M 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Sitalembic M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalembic M 50mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sitalembic M 50mg/500mg tablets with a meal.

How Sitalembic M 50mg/500mg Tablet works:

Sitalembic M, a 50mg/500mg tablet, combines sitagliptin and metformin to improve blood glucose management. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to more effective blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitalembic M 50mg/500mg tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitalembic M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitalembic M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalembic M 50mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. The medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from using Sitalembic M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitalembic M 50mg/500mg Tablet :

Should you forget a Sitalembic M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalembic M 50mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Sitalembic M 50mg/500mg Tablet

Sitalembic M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar when combined with a healthy diet and physical activity. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin blocks DPP-4, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Prolonged Sitalembic M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This medication impairs the body's ability to absorb vitamin B12 from the gastrointestinal tract. Untreated deficiency may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, has been proposed by some investigators.
Sitalembic M 50mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Individuals with hypersensitivity to any constituent of Sitalembic M 50mg/500mg Tablet should refrain from its use. This medication is contraindicated in patients experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitalembic M 50mg/500mg Tablet is unsafe due to a heightened risk of lactic acidosis.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Indeed, Sitagliptin/Metformin 50mg/500mg tablets can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin, prompting its avoidance in individuals with pre-existing kidney impairment, the elderly, or those who consume significant alcohol. Manifestations of lactic acidosis might encompass muscular aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sitagliptin/Metformin and seek immediate medical attention.
The combined medication Sitalembic M 50mg/500mg Tablet, containing sitagliptin and metformin, manages type 2 diabetes mellitus in adults. This treatment enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin, by suppressing DPP4 enzyme activity, boosts pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalembic M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any constituent or inactive ingredient in Sitalembic M 50mg/500mg Tablet should not use this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Indeed, Sitagliptin/Metformin 50mg/500mg tablets can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin, prompting its avoidance in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Presenting symptoms may involve muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Indeed, prolonged Sitalembic M 50mg/500mg Tablet use can lead to vitamin B12 deficiency. This medication hinders the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia and neurological complications, manifesting as tingling or numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure that it remains inaccessible to children, pets, and other individuals.
The tablet Sitalembic M, containing 50mg Sitagliptin and 500mg Metformin, treats type 2 diabetes mellitus in adults. This dual-action medication enhances blood sugar control when combined with a healthy diet and physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, thereby boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitalembic M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis can occur. Prolonged administration may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 50mg/500mg Tablet ingredient or inactive component should not use this medication. Furthermore, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 50mg/500mg Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Sitalembic M 50mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates avoidance in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitalembic M 50mg/500mg tablets can lead to vitamin B12 deficiency. This medication disrupts the body's absorption of vitamin B12 in the gastrointestinal tract. Untreated deficiency can result in anemia and neurological complications, manifesting as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, according to some studies, include supplemental vitamin B12 at least annually.
Store this medication in its original, tightly sealed container, following the storage instructions provided on the packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and other individuals.
Sitalembic M 50mg/500mg T...
138
MRP 161
14% off